Doctors Told Him He’d End Up in a Wheelchair. He Found a Cure For His Illness and Built a Company Around It.

Momo Vuyisich's story is a testament to the power of personal experience driving innovation. After being told he'd end up in a wheelchair due to his illness, Vuyisich took matters into his own hands and began researching the microbiome, ultimately finding a cure for his condition. This experience led him to create Viome, a company focused on harnessing the potential of the microbiome to prevent disease. The fact that Vuyisich was able to turn his personal struggle into a business opportunity highlights the growing importance of the microbiome in the healthcare industry.

The medical establishment's slow adoption of microbiome research is surprising, given the rapidly growing body of evidence suggesting its crucial role in human health. The microbiome has been linked to a wide range of diseases, from digestive issues to mental health conditions. As a result, companies like Viome are at the forefront of a potentially revolutionary shift in the way we approach healthcare. By developing products and services that target the microbiome, these companies are poised to disrupt traditional treatment methods and create new opportunities for disease prevention.

As the microbiome industry continues to grow, it's worth watching how Viome and similar companies navigate the regulatory landscape and secure funding to further their research. Additionally, it will be interesting to see how the medical establishment responds to the accumulating evidence on the microbiome's importance, and whether we can expect to see a significant shift in the way diseases are treated and prevented in the near future. With the potential for huge returns on investment, it's likely that we'll see increased interest and activity in the microbiome space, and companies like Viome are well-positioned to lead the charge.

Originally reported by entrepreneur.com. SupportWire adds analysis for business & startups readers.